WASHINGTON -- The head of the Food and Drug Administration said Friday his agency has provided new guidance to the White House after data suggested that a rapid COVID-19 test used by President Donald ...
ABBOTT PARK, Ill., Jan. 26, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received CE Mark for two new uses of its Panbio™ COVID-19 Ag Rapid Test Device for the detection of the ...
Abbott Laboratories in August won Food and Drug Administration emergency clearance for its portable test for the coronavirus strain Covid-19 that sells for just $5 and allow for “frequent mass testing ...
FDA Emergency Use Authorization permits asymptomatic, non-prescription, over-the-counter self use for people with or without symptoms The BinaxNOW COVID-19 Self Test is identical to the ...
Due to an increase in the campus COVID-19 positivity rate, the University began requiring students to complete one Abbott rapid antigen test in addition to the typical Color test each week. According ...
NORTH CHICAGO, IL — As demand for COVID-19 testing skyrockets during the omicron surge, officials at Abbott Labs hope to soon be making twice as many BinaxNOW rapid test kits as the company produced ...
Abbott CEO Robert Ford said the company's rapid diagnostic tests for Covid-19 began to be shipped to U.S. retail outlets Monday, April 19. Demand for Abbott’s portfolio of tests for Covid-19 continued ...
ABBOTT PARK, Ill., March 31, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for over-the-counter, non ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback